Term ends Apr 19, 2032 · High confidence
20-year base term ends Apr 19, 2032
Held by Merrimack Pharmaceuticals, Inc.
Filed Apr 19, 2012 as application 13/451,135 · Granted Jul 2, 2013
Base term, 20 years from filing
Today
2012
2032
Clock starts
Apr 19, 2012
Apr 19, 2012
Term ends
Apr 19, 2032
Apr 19, 2032
Granted
Jul 2, 2013
Jul 2, 2013
base term
fee events
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
None
Terminal disclaimer
No disclaimer on this record.
3 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
4
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.
This patent's term is its 20-year base term, with no adjustment for prosecution delay. All three maintenance fees are recorded paid; no more fees are due. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Apr 19, 2012, when this application, 13/451,135, was filed | Apr 19, 2032 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 3 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Apr 19, 2032 | High confidence |
This family
| US 8,476,409 | this patent Apr 2032 | Apr 2032 |
| US 9,556,274 | Lapsed on the fee record Jan 2021 | Jan 2021 |
| US 9,527,914 | Lapsed on the fee record Dec 2020 | Dec 2020 |
| US 9,938,346 | In force Apr 2032 | Apr 2032 |
Every application listed has its file history here. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Jan 14, 2013 Reel 29624, frame 907 | Baum, Jason; Johnson, Bryan; Lugovskoy, Alexey Alexandrovich; Xu, Lihui; Kohli, Neeraj; Fitzgerald, Jonathan Basil; Adams, Sharlene | Merrimack Pharmaceuticals, Inc. | Assignment of Assignor's Interest |
| Jun 17, 2014 Reel 33114, frame 554 | Baum, Jason; Johnson, Bryan; Lugovskoy, Alexey Alexandrovich; Xu, Lihui; Kohli, Neeraj; Fitzgerald, Jonathan Basil; Adams, Sharlene | Merrimack Pharmaceuticals, Inc. | Assignment of Assignor's Interest |
| Dec 28, 2015 Reel 37394, frame 285 | Merrimack Pharmaceuticals, Inc. | U.S. Bank National Association, as Collateral Agent | Security Interest |
| Apr 14, 2017 Reel 42254, frame 349 | U.S. Bank National Association | Merrimack Pharmaceuticals, Inc. | Release of Security Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Apr 2032
Term ends Apr 19, 2032. No further fees fall due before then
Citations
24
later US patents cite this one
That is top 25% of utility patents granted in 2013 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.